AVEO Pharma (AVEO) Blows Up Q1 Views
Tweet Send to a FriendGet Alerts AVEO Hot Sheet
Trade AVEO Now!
AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) reported Q1 EPS of $2.28, $2.98 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $133.61 million versus the consensus estimate of $6.28 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Streetinsider.com After-Hours Movers 05/23: (BLOX) (P) (MRVL) Higher; (SHLD) (AVEO) (CRM)
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
